Siemens Healthcare Diagnostics can tell you what your problem is. The subsidiary of Siemens Healthcare offers a comprehensive array of diagnostic products, from in vitro diagnostic testing assays and to laboratory analysis instruments. Siemens Healthcare Diagnostics' lead products include RapidLab blood gas analyzers, ADVIA hematology and immunoassay systems, Dimension chemical laboratory automation systems, VERSANT molecular testing systems, DCA Vantage diabetes testing systems, and Viva drug testing systems. Its products are sold globally through direct sales forces and through distribution agreements. Siemens Healthcare Diagnostics also provides labs with information technology and consulting services.
Siemens Healthcare Diagnostics serves about 30,000 customers in some 120 countries. It has direct operations in France, Germany, Italy, Japan, Korea, the Netherlands, Poland, Spain, the UK, and the US.
With operations around the globe and a product lineup including systems for routine testing, hematology, and microbiology, Siemens Healthcare Diagnostics is a top-ranking of providers in the global clinical laboratory market. The company's analysis equipment and related consumables (about 900 testing products including chemical and DNA testing assays) are used in clinical laboratories to detect a range of conditions from cancer and cardiovascular disease to kidney problems and infections.
Sales and Marketing
Siemens Healthcare Diagnostics' biggest customer segment is hospitals, specifically the clinical diagnostic laboratories located within acute care hospital facilities; it also serves independent lab operators, research labs, and physician practice labs. Products are delivered to these customers via wholesalers and hospital group purchasing organizations.
Siemens Healthcare Diagnostics regularly broadens its product portfolio with new offerings in areas such as disease monitoring and infectious disease testing, with the goal of helping clients streamline and speed workflow processes and improve patient outcomes. To that end Siemens Healthcare Diagnostics is launching new tests in the increasingly popular field of molecular diagnostics, and it is upgrading its chemistry analysis systems to increase functionality and improve sample processing times.
The company formed partnerships with drugmakers Viiv Healthcare and Tocagen in 2012 to work on companion diagnostic tests in fields including HIV and cancer. Companion diagnostics are part of the growing field of personalized medicine, where tests show how well a drug will work on a certain patient based on the patient's genetic traits.
German parent company Siemens formed the Siemens Healthcare Diagnostics subsidiary by combining acquired firms Bayer HealthCare Diagnostics and Diagnostic Products Corporation in 2007, lumping them together under the broader Healthcare division. Bayer then added the $7 billion buy of diagnostics maker Dade Behring to the Siemens Healthcare Diagnostics organization later that year.